In primary prevention trials statins slightly reduce atherosclerotic events but not total serious adverse events.1 Another paradox is that many patients have muscle pain, fatigue, or weakness that...
from Latest headlines from BMJ http://ift.tt/23E0pbo
via IFTTT
No comments:
Post a Comment